1

2
Deroy Patrick, Faucher Anne Marie, Gagnon Alexandre, Landry Serge, Morin Sébastien, O Meara Jeffrey, Simoneau Bruno, Thavonekham Bounkham, Yoakim Christiane: Non nucleoside reverse transcriptase inhibitors. Boehringer Ingelheim, International, Boehringer Ingelheim, Pharma & Co Kg, Deroy Patrick, Faucher Anne Marie, Gagnon Alexandre, Landry Serge, Morin Sébastien, O Meara Jeffrey, Simoneau Bruno, Thavonekham Bounkham, Yoakim Christiane, BERNIER Louise G, December 15, 2005: WO/2005/118575 (7 worldwide citation)

The invention relates to compounds of formula (I) wherein Ar, X, R1, R2, R3 and R4 are as defined herein and pharmaceutical compositions thereof useful, either alone or in combination with other therapeutic agents as reverse transcriptase inhibitors against wild type and single or double mutant stra ...


3

4

5
Beaulieu Pierre L, Forgione Pasquale, Gagnon Alexandre, Godbout Cedrickx, Naud Julie, Poirier Martin, Rancourt Jean, Stammers Timothy A, Thavonekham Bounkham: Viral polymerase inhibitors. Boehringer Ingelheim Int, May 19, 2010: EP2185539-A1

Compound of Formula I: wherein, R2, R5 and R6 are defined herein, are useful as inhibitors of the hepatitis C virus NS5B polymerase


6

7

8

9
Bonneau Pierre, Deroy Patrick, Gagnon Alexandre, O Meara Jeffrey, Simoneau Bruno, Yoakim Christiane: Derives de benzophenone a base dalkynyle utilises comme inhibiteurs de transcriptase inverse de non nucleoside, Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors. Boehringer Ingelheim International, Boehringer Ingelheim International, Looper Ywe J, June 21, 2011: CA2577144

Compounds of formula (I):(see formula I) wherein Q, R1, R2, R3, R4, R6 and R7 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against HIV. In particular, the compounds are active against wild type and single or double mutant strains of HIV.


10